Heidelberg Pharma AG Revenue Growth & History (HPHA)

Heidelberg Pharma AG reported €1.5M in revenue for fiscal 2025, a decrease of 78.69% from the previous fiscal year.

View full Heidelberg Pharma AG company overview

Heidelberg Pharma AG annual revenue and growth

Heidelberg Pharma AG annual revenue

Fiscal yearPeriod endedRevenueChangeGrowth
20252025-11-30€1.5M−€5.4M−78.69%
20242024-11-30€6.8M−€3.0M−30.53%
20232023-11-30€9.9M−€8.7M−46.73%
20222022-11-30€18.5M€16.8M+957.71%
20212021-11-30€1.8M−€6.7M−79.39%
20202020-11-30€8.5M€1.2M+16.14%
20192019-11-30€7.3M€3.6M+99.18%
20182018-11-30€3.7M€1.8M+93.16%
20172017-11-30€1.9M€540,000+39.71%
20162016-11-30€1.4M−€920,000−40.35%
20152015-11-30€2.3M−€1.3M−36.67%
20142014-11-30€3.6M−€9.7M−72.97%
20132013-11-30€13.3M−€2.8M−17.47%
20122012-11-30€16.1M€6.3M+63.36%
20112011-11-30€9.9M€9.9M
20102010-11-30€0

Heidelberg Pharma AG revenue growth trends

Over the last five reported fiscal years, revenue declined from €8.5M to €1.5M, a compound annual decline of 29.68%. Heidelberg Pharma AG's latest reported quarter, Q2 2026, generated €4.3M in revenue, an increase of 3566.19% year over year.

About the data

What revenue means

Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.

Financial data

Standardized company financials

TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.

Review Heidelberg Pharma AG source filings ↗

Community posts

It’s quiet here.

No posts about HPHA yet. Start the conversation.

Write the first post